These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25023534)

  • 1. HELOW: a program for testing extreme homogeneity in meta-analysis.
    Zintzaras E; Ioannidis JP
    Comput Methods Programs Biomed; 2014 Nov; 117(2):383-6. PubMed ID: 25023534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extreme between-study homogeneity in meta-analyses could offer useful insights.
    Ioannidis JP; Trikalinos TA; Zintzaras E
    J Clin Epidemiol; 2006 Oct; 59(10):1023-32. PubMed ID: 16980141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing homogeneity of proportion ratios for stratified correlated bilateral data in two-arm randomized clinical trials.
    Pei Y; Tian GL; Tang ML
    Stat Med; 2014 Nov; 33(25):4370-86. PubMed ID: 24974954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test homogeneity of odds ratio in a randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2009 Sep; 19(5):916-32. PubMed ID: 20183452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing for homogeneity in meta-analysis I. The one-parameter case: standardized mean difference.
    Kulinskaya E; Dollinger MB; Bjørkestøl K
    Biometrics; 2011 Mar; 67(1):203-12. PubMed ID: 20528863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesizer 1.0: a varying-coefficient meta-analytic tool.
    Krizan Z
    Behav Res Methods; 2010 Aug; 42(3):863-70. PubMed ID: 20805608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of pairs of survival curves under heterogeneity: a Poisson correlated gamma-frailty approach.
    Fiocco M; Putter H; van Houwelingen JC
    Stat Med; 2009 Dec; 28(30):3782-97. PubMed ID: 19899066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-CART: A tool to identify interactions between moderators in meta-analysis.
    Li X; Dusseldorp E; Meulman JJ
    Br J Math Stat Psychol; 2017 Feb; 70(1):118-136. PubMed ID: 28130936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I error and statistical power of the Mantel-Haenszel procedure for detecting DIF: a meta-analysis.
    Guilera G; Gómez-Benito J; Hidalgo MD; Sánchez-Meca J
    Psychol Methods; 2013 Dec; 18(4):553-71. PubMed ID: 24127986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothesis tests for population heterogeneity in meta-analysis.
    Viechtbauer W
    Br J Math Stat Psychol; 2007 May; 60(Pt 1):29-60. PubMed ID: 17535578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?
    Huedo-Medina TB; Sánchez-Meca J; Marín-Martínez F; Botella J
    Psychol Methods; 2006 Jun; 11(2):193-206. PubMed ID: 16784338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fitting semiparametric additive hazards models using standard statistical software.
    Schaubel DE; Wei G
    Biom J; 2007 Aug; 49(5):719-30. PubMed ID: 17638295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncertainties beyond statistics in Monte Carlo simulations.
    Hughes HG
    Radiat Prot Dosimetry; 2007; 126(1-4):45-51. PubMed ID: 17766264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling the risk of spurious findings from meta-regression.
    Higgins JP; Thompson SG
    Stat Med; 2004 Jun; 23(11):1663-82. PubMed ID: 15160401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proportional hazards regression for cancer studies.
    Ghosh D
    Biometrics; 2008 Mar; 64(1):141-8. PubMed ID: 17573863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A set of SAS macros for calculating and displaying adjusted odds ratios (with confidence intervals) for continuous covariates in logistic B-spline regression models.
    Gregory M; Ulmer H; Pfeiffer KP; Lang S; Strasak AM
    Comput Methods Programs Biomed; 2008 Oct; 92(1):109-14. PubMed ID: 18603325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of underlying risk as a source of heterogeneity in meta-analyses: a simulation study of Bayesian and frequentist implementations of three models.
    Dohoo I; Stryhn H; Sanchez J
    Prev Vet Med; 2007 Sep; 81(1-3):38-55. PubMed ID: 17477995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved inference for fixed-effects meta-analysis of 2 × 2 tables.
    Qijun Li K; Rice K
    Res Synth Methods; 2020 May; 11(3):387-396. PubMed ID: 32092228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Odds ratio for 2 × 2 tables: Mantel-Haenszel estimator, profile likelihood, and presence of surrogate responses.
    Banerjee B; Biswas A
    J Biopharm Stat; 2014; 24(3):649-59. PubMed ID: 24697719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Related causal frameworks for surrogate outcomes.
    Joffe MM; Greene T
    Biometrics; 2009 Jun; 65(2):530-8. PubMed ID: 18759836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.